Source: Google NewsPublished on 2021-02-22
Related Articles:
- Monthly Research Review – September 2019 September 30, 2019 At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during September 2019. The post is divided into seven parts based on the type of research: Basic biology Disease mechanism Clinical research New clinical trials Clinical trial news Other news Review…
- The road ahead: 2021 January 25, 2021 # # # # At the start of each year, it is a useful practise to layout what is planned over the next 12 months. The events that are scheduled for the year to come, so that we can keep an eye out for them. Obviously, where 2021 will end actually is unpredictable, but an outline of what is scheduled…
- Monthly Research Review – August 2019 August 31, 2019 At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during August 2019. The post is divided into seven parts based on the type of research: Basic biology Disease mechanism Clinical research New clinical trials Clinical trial news Other news Review…
- C4 poaches new CMO after signing $900M clinical development deal with Roche - FierceBiotech March 14, 2019 C4 poaches new CMO after signing $900M clinical development deal with Roche FierceBiotechC4 Therapeutics has hired Adam Crystal, M.D., Ph.D., a senior director at the Novartis Institutes for BioMedical Research, to be its new chief medical officer and ...
- The road ahead: 2020 January 5, 2020 Here at the SoPD, we are primarily interested in disease modification for Parkinson’s. While there is a great deal of interesting research exploring the causes of the condition, novel symptomatic therapies, and other aspects of Parkinson’s, my focus is generally on the science seeking to slow, stop or reverse the condition. At the start of each year, it is a…
- Ask the expert: How to spot fake Parkinson’s medicines online February 27, 2020 In the third in our expert series, we talk to Mike Isles, Executive Director of the Alliance for Safe Online Pharmacy in the EU, about the growing problem of fake Parkinson’s medicines advertised and sold online – from their shocking prevalence to top tips on how to stay safe Firstly, could you explain to our readers what falsified medicines are?…
- Cognitive Behavioral Therapy for Anxiety in Parkinson's Disease: A Randomized Controlled Trial February 22, 2021 Mov Disord. 2021 Feb 22. doi: 10.1002/mds.28533. Online ahead of print.ABSTRACTBACKGROUND: Anxiety disorders are among the most prevalent and disabling neuropsychiatric syndromes in patients with Parkinson's disease (PD), but no randomized controlled treatment trials of anxiety have been published to date.OBJECTIVE: The aim of this study was to assess the effectiveness of cognitive behavioral therapy (CBT) in the treatment of…
- Cognitive Behavioral Therapy for Anxiety in Parkinson's Disease: A Randomized Controlled Trial February 22, 2021 Mov Disord. 2021 Feb 22. doi: 10.1002/mds.28533. Online ahead of print.ABSTRACTBACKGROUND: Anxiety disorders are among the most prevalent and disabling neuropsychiatric syndromes in patients with Parkinson's disease (PD), but no randomized controlled treatment trials of anxiety have been published to date.OBJECTIVE: The aim of this study was to assess the effectiveness of cognitive behavioral therapy (CBT) in the treatment of…
- Cognitive Behavioral Therapy for Anxiety in Parkinson's Disease: A Randomized Controlled Trial February 22, 2021 Mov Disord. 2021 Feb 22. doi: 10.1002/mds.28533. Online ahead of print.ABSTRACTBACKGROUND: Anxiety disorders are among the most prevalent and disabling neuropsychiatric syndromes in patients with Parkinson's disease (PD), but no randomized controlled treatment trials of anxiety have been published to date.OBJECTIVE: The aim of this study was to assess the effectiveness of cognitive behavioral therapy (CBT) in the treatment of…
- Parkinson's Disease News - Editor's Picks (Archive 2016.11) March 17, 2017 Newsfeed: PD News PD Research News PD Fitness News PD Boxing News PD Web Articles PD Blogs PD Editor's Picks PD Twitter Newsfeed Neurons Paralyze Us During REM SleepIt will also be most useful in the study of Parkinson’s disease, since these pathologies are related. This work was published on December 12, 2016 on the website of the journal Brain.…
- Cavion’s New CMO to Lead Cav3 Platform Development for Neurological Diseases August 21, 2017 The biopharmaceutical company Cavion announced the appointment of a new executive vice president of research and development and chief medical officer to lead efforts advancing therapies based on the company’s T-type calcium channel (Cav3) platform targeting neurological diseases such as Parkinson’s disease (PD). Spyridon “Spyros” Papapetropoulos, MD, PhD, has been named the company’s new executive vice president of research and development and CMO. Papapetropoulos has extensive…
- Monthly Research Review – January 2021 January 31, 2021 # # # # At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during the previous 4 weeks. The post is divided into eight parts based on the type of research: Basic biology Disease mechanism Clinical research New clinical trials Clinical…
- September 28, 2019 - Parkinson FIT Weekend Update September 28, 2019 This Week’s Highlights: PD vs. Sleep (Sleeping with the enemy); smart watch fall detection; Every Day is Opening Day; Could an existing prostrate drug really slow down PD progression?; Can exergaming really motivate couch potatoes or is it an excuse for overpriced exercise equipment that gets used for only a few months before it becomes a dust collecting eyesore in…
- 4-Part Exercise Mini-Series: Core Strengthening Exercises for Parkinson’s April 8, 2019 Written by Dr. Sarah King, PT, DPT “You need to focus on your core!” This buzz word – “the core” – exploded in the late 80s (anyone remember the Abdominizer?) and infomercials have taken the term and run with it, making billions of dollars in the process. Contrary to popular belief, and to the detriment of ab products everywhere, you…
- Monthly Research Review – November 2020 November 30, 2020 At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during November 2020. The post is divided into seven parts based on the type of research: Basic biology Disease mechanism Clinical research New clinical trials Clinical trial news Conferences/lectures Other news…
- AMP-PD is here November 22, 2019 Today the US National Institute of Health (NIH) announced the opening of the data portal for the Accelerating Medicines Partnership for Parkinson’s disease (or AMP-PD) initiative. This research program is a MASSIVE collaborative effort between the NIH, multiple biopharmaceutical/life sciences companies, and non-profit organisations. It involves a pooling together of “well characterized cohorts with existing biosamples and clinical data”,…
- New Large-Scale Data Portal Will Promote Parkinson’s Treatment Development November 27, 2019 The Accelerating Medicines Partnership (AMP) for Parkinson’s (PD) has opened a data portal with de-identified information from 4,298 Parkinson’s patients and healthy control subjects for use by scientists seeking new treatments for the progressive neurodegenerative disease. With unprecedented access to a data pool of this scale, investigators now can examine intricate data sets and conduct full-scale genomic analyses. “AMP PD…
- New Large-Scale Data Portal Will Promote Parkinson’s Treatment Development November 27, 2019 The Accelerating Medicines Partnership (AMP) for Parkinson’s (PD) has opened a data portal with de-identified information from 4,298 Parkinson’s patients and healthy control subjects for use by scientists seeking new treatments for the progressive neurodegenerative disease. With unprecedented access to a data pool of this scale, investigators now can examine intricate data sets and conduct full-scale genomic analyses. “AMP PD…
- New Large-Scale Data Portal Will Promote Parkinson’s Treatment Development November 27, 2019 The Accelerating Medicines Partnership (AMP) for Parkinson’s (PD) has opened a data portal with de-identified information from 4,298 Parkinson’s patients and healthy control subjects for use by scientists seeking new treatments for the progressive neurodegenerative disease. With unprecedented access to a data pool of this scale, investigators now can examine intricate data sets and conduct full-scale genomic analyses. “AMP PD…
- What Parkinson’s Medicines Cause Nutrient Depletions? May 13, 2019 A multitude of options – some natural and some not – are available for treating symptoms of Parkinson’s disease. The most popular of all options is taking Parkinson’s medicines which offer welcome relief to some. These medicines do not offer relief for everyone. Thankfully, many do benefit. This is the same result for any of … Continue reading What Parkinson’s…
- What Parkinson’s Medicines Cause Nutrient Depletions? May 13, 2019 A multitude of options – some natural and some not – are available for treating symptoms of Parkinson’s disease. The most popular of all options is taking Parkinson’s medicines which offer welcome relief to some. These medicines do not offer relief for everyone. Thankfully, many do benefit. This is the same result for any of … Continue reading What Parkinson’s…
- What Parkinson’s Medicines Cause Nutrient Depletions? May 13, 2019 A multitude of options – some natural and some not – are available for treating symptoms of Parkinson’s disease. The most popular of all options is taking Parkinson’s medicines which offer welcome relief to some. These medicines do not offer relief for everyone. Thankfully, many do benefit. This is the same result for any of … Continue reading What Parkinson’s…